CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Tuesday reported fiscal third-quarter profit of $6.8 million.

The Cincinnati-based company said it had net income of 16 cents per share. Earnings, adjusted for non-recurring costs, were 18 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 17 cents per share.

The diagnostic test maker posted revenue of $51.7 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $52 million.

Meridian Bioscience expects full-year earnings in the range of 69 cents to 72 cents per share, with revenue in the range of $209 million to $214 million.

Meridian Bioscience shares have risen almost 9 percent since the beginning of the year. The stock has climbed slightly more than 9 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIVO at https://www.zacks.com/ap/VIVO